News

Pelvipharm at the Congress of the ESSM (European Society for Sexual Medicine) in Bari, Italy, 8-10 February, 2024.   François Giuliano will present one abstract during the podium session entitled “Basic science”:    “LIB-01, a novel promising oral drug under development for the treatment of erectile dysfunction (ED) – a summary of nonclinical studies”. F. Giuliano, D. Gorny, M. Razanakolona,…

Pelvipharm at the 24th Annual Fall Scientific Meeting in San Diego, USA, 16-19 November, 2023. François Giuliano will present one abstract :  “Overview of nonclinical studies of LIB-01, a novel promising oral drug under development for treatment of erectile dysfunction”. François Giuliano, Diane Gorny, Mahita Razanakolona, Delphine Behr-Roussel, Rana Assaly, Charlotta Gauffin Please come and see us, we will be happy…

Pelvipharm at the 15th World Congress on Endometriosis in Edinburg, May 3rd-6th, 2023.   Delphine Behr-Roussel  will present : ” Effect of estrous cycle stage on establishment of a endometriosis rodent model to evaluate the effect of new therapeutic strategies ” R. Assaly, S. Compagnie, L. Allimonnier, M. Bracconi, F. Giuliano, L. Alexandre, D. Behr-Roussel.   Please come and…

Presentation at the International Continence Society in Toronto, September 27th-29th, 2023. Julien Ratelade from EG427 presented the results of a project performed in collaboration with Pelvipharm: ” Intravesical administration of EG110A, a novel nonreplicative Herpes Simplex Virus (HSV-1)-derived vector expressing the light chain of botulinum toxin F, inhibits C-type fibers in an acute intravesical capsaicin rat model ” Ratelade J1, Faugeroux J2, Behr-Roussel…